Johnson & Johnson Sees Unusual Call Activity Totaling $1.33M Even as Stock Slides 2.44%
By TrendSpider Editor
Johnson & Johnson attracted notable bullish options activity on Thursday, June 18, 2026, with three unusual call contracts generating a combined premium of $1,326,840 even as shares fell 2.44% to $228.315. The largest single contract, a $250 strike call expiring June 17, 2027, alone accounted for $8
Johnson & Johnson Sees Unusual Call Activity Totaling $1.33M Even as Stock Slides 2.44%
Johnson & Johnson attracted notable bullish options activity on Thursday, June 18, 2026, with three unusual call contracts generating a combined premium of $1,326,840 even as shares fell 2.44% to $228.315. The largest single contract, a $250 strike call expiring June 17, 2027, alone accounted for $894,000 in premium across 600 contracts. With JNJ trading well above its 52-week low of $149.04 but still below its 52-week high of $251.705, the options flow suggests some traders are positioning for a recovery toward those prior highs over the next year.
Key Drivers of the JNJ Stock Move
- Main Catalyst: Three unusual call contracts totaling $1,326,840 in premium hit the tape on a day when JNJ shares dropped 2.44%. The flow was exclusively calls, with zero puts recorded, pointing to a distinctly one-sided bullish posture from options traders despite the intraday weakness.
- Bull Case: The dominant contract, a $250 call expiring June 17, 2027, drew 600 contracts at 173% of open interest, signaling conviction that JNJ can reclaim levels near its 52-week high of $251.705 within the next 12 months. A shorter-dated $227.50 call expiring June 26, 2026 is already in-the-money with the stock at $228.315, and posted a 727% open interest ratio on 80 contracts, suggesting aggressive near-term accumulation.
- Bear Case: The same-day price decline of 2.44% underscores real near-term selling pressure. The $230 strike call expiring July 17, 2026 attracted the highest contract volume at 640 but represented only 9% of open interest, the weakest conviction reading of the three, and is currently out-of-the-money, meaning JNJ must reverse its recent slide quickly for that position to pay off.
The forward setup is mixed but leans cautiously constructive on a longer-duration basis. The concentration of premium in the June 2027 expiry implies institutional or semi-institutional players are not counting on an immediate snapback but are willing to pay for exposure over a full calendar year. At $228.315, JNJ sits roughly $23 below its 52-week high, leaving meaningful upside if the company can stabilize. Traders watching the near-term will want to see price reclaim $230 quickly, as both the short-dated call expirations in late June and mid-July require at least modest follow-through buying to move into profitable territory.
JNJ Unusual Options Activity
- Contract 1: Call | Strike: $250 | Expiry: June 17, 2027 | Volume: 600 | Open Interest: 173% | Out-of-the-money | Premium: $894,000
- Contract 2: Call | Strike: $227.50 | Expiry: June 26, 2026 | Volume: 80 | Open Interest: 727% | In-the-money | Premium: $29,640
- Contract 3: Call | Strike: $230 | Expiry: July 17, 2026 | Volume: 640 | Open Interest: 9% | Out-of-the-money | Premium: $403,200
All three contracts were calls, with zero puts recorded. Total premium across all unusual contracts reached $1,326,840, with the June 2027 expiry representing the largest single outlay at $894,000. The 727% open interest ratio on the June 26 call stands out as the most aggressive relative to existing positioning, while the July $230 call posted the highest raw volume at 640 contracts.
JNJ Seasonality
Mid-June historically marks the lead-in to JNJ's second-quarter earnings season, a period when large-cap healthcare names often see increased options positioning as traders hedge or speculate ahead of results. The clustering of near-dated expirations in late June and mid-July aligns with that pre-earnings positioning pattern.
JNJ Relative Performance
JNJ's 2.44% decline on June 18 stands out as notable underperformance for a large-cap defensive healthcare name, which typically experiences muted single-session swings. Trading at $228.315 against a 52-week range of $149.04 to $251.705, JNJ remains in the upper half of its annual range, but the day's move suggests the stock is facing sector-level or company-specific headwinds that are overriding the defensive characteristics that typically buffer names like JNJ during periods of broader market volatility.